Policy in Focus

Market Access

Unpack the impact of Most-Favoured Nations in GLOBE and GUARD pricing models, and TrumpRx, with Alice Valder Curran's clear policy overview.

News

Novartis' oral BTK inhibitor Rhapsido has had its label expanded in the US to include a second indication that causes chronic hives.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.